Figure 3
From: Impact of benzodiazepine consumption reduction on future burden of dementia
Projections of life expectancies without dementia (in years) at each age from 65 to 100 in France in 2040 for women (a) and men (b) for the main analysis and the two sensitivity analyses and for 2 scenarios of BZD use. Grey lines, scenario 0 (constant chronic use of BZD); black lines, scenario 2 (incidence of chronic use of BZD null from 2020); solid lines, main analysis (decreasing dementia incidence and overmortality of exposed subjects); dashed lines, first sensitivity analysis (constant dementia incidence); dotted lines, second sensitivity analysis (no effect of exposure on mortality).
